{"adverse_reactions":["Adverse Reactions"],"animal_pharmacology_and_or_toxicology":["Animal Pharmacology and Toxicology"],"clinical_pharmacology":["Clinical Pharmacology"],"contraindications":["Contraindications"],"description":["Description"],"dosage_and_administration":["Dosage and Administration"],"effective_time":"20230417","id":"f98af2e8-8ca4-75e2-e053-6394a90a5063","indications_and_usage":[""],"openfda":{},"overdosage":["Overdosage"],"package_label_principal_display_panel":["270","61919-270-30"],"patient_medication_information":["Patient Information"],"precautions":["Precautions"],"set_id":"25c33cb5-4244-3721-e054-00144ff8d46c","spl_product_data_elements":["MINOCYCLINE HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE MINOCYCLINE MAGNESIUM STEARATE STARCH, CORN FERROSOFERRIC OXIDE SHELLAC GELATIN POTASSIUM HYDROXIDE TITANIUM DIOXIDE PROPYLENE GLYCOL gray opaque cap, white opaque body RX696"],"spl_unclassified_section":["SPL Unclassified Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of minocycline hydrochloride capsules, USP and other antibacterial drugs, minocycline hydrochloride capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria."],"version":"7","warnings":["Warnings"]}